This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bajunirwe, F. Articles by Sethi, A. K. Search for Related Content PubMed PubMed Citation Articles by Bajunirwe, F. Articles by Sethi, A. K. Pubmed/NCBI databases Medline Plus Health Information AIDS Medicines Rural Health Concerns Social Bookmarking                         What's this?

Adherence and Treatment Response Among HIV-1-Infected Adults Receiving Antiretroviral Therapy in a Rural Government Hospital in Southwestern Uganda

Department of Community Health, Mbarara University of Science and Technology, Mbarara, Uganda, fbaj{at}yahoo.com

Eric J. Arts, PhD

Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio

Daniel J. Tisch, PhD, MPH

Department of Epidemiology and Biostatistics Case Western Reserve University School of Medicine, Cleveland, Ohio

Charles H. King, MD

Department of Epidemiology and Biostatistics Case Western Reserve University School of Medicine, Cleveland, Ohio

Sara M. Debanne, PhD

Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio

Ajay K. Sethi, PhD, MHS

Department of Epidemiology and Biostatistics Case Western Reserve University School of Medicine, Cleveland, Ohio, Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

Background. Large-scale, government-based antiretroviral therapy (ART) programs in rural areas of resource-poor countries remain largely unevaluated. Methods. We conducted a retrospective review of all patients receiving ART (n = 399) to assess survival and retention in care and a prospective evaluation of patients on ART for at least 6 months (n = 175). We used 3-day self-report to measure adherence. Results. The probability (95% confidence interval [CI]) of surviving and remaining in care was 0.76 (0.72, 0.81) at 1 year. Men and patients with advanced disease were more likely to die or be lost to follow-up. At baseline, 149 (85%) reported 100% adherence. Nonadherence was associated with lack of suppression of viral replication (odds ratio [OR] = 4.5; 95% CI: 1.8, 11.5). Missing a scheduled clinic visit and lack of disclosure of HIV status were associated with nonadherence. Conclusion. Viral suppression was high, but counseling to include HIV disclosure to family and keeping scheduled clinic appointments may improve long-term adherence and treatment outcomes.

Key Words: HIV • antiretroviral therapy • adherence • virologic suppression • rural settings • Uganda

References

• Severe P., Leger P., Charles M., et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med. 2005;353:2325-2334.[Abstract/Free Full Text]
• Spacek LA, Shihab HM, Kamya MR, et al. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clin Infect Dis. 2006;42:252-259.[CrossRef][Medline] [Order article via Infotrieve]
• Weidle PJ, Wamai N., Solberg P., et al. Adherence to antiretroviral therapy in a home-based aids care programme in rural Uganda. Lancet. 2006;368:1587-1594.[CrossRef][Medline] [Order article via Infotrieve]
• Nachega JB, Stein DM, Lehman DA, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses. 2004;20: 1053-1056.[CrossRef][Medline] [Order article via Infotrieve]
• Byakika-Tusiime J., Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16:38-41.[Abstract/Free Full Text]
• van Oosterhout JJ, Bodasing N., Kumwenda JJ, et al. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health. 2005;10:464-470.[CrossRef][Medline] [Order article via Infotrieve]
• Laniece I., Ciss M., Desclaux A., et al. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS. 2003;17(suppl 3):S103-S108.[CrossRef][Medline] [Order article via Infotrieve]
• Arnsten JH, Demas PA, Farzadegan H., et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33:1417-1423.[CrossRef][Medline] [Order article via Infotrieve]
• Keiser O., Orrell C., Egger M., et al. Public-health individual approaches to antiretroviral therapy: township South Africa Switzerland compared. PLoS Med. 2008;5:e148. doi:10.1371/journal.pmed.0050148.[CrossRef][Medline] [Order article via Infotrieve]
• Laurent C., Kouanfack C., Koulla-Shiro S., et al. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet. 2004;364:29-34.[CrossRef][Medline] [Order article via Infotrieve]
• Bourgeois A., Laurent C., Mougnutou R., et al. Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon. Antivir Ther. 2005;10: 335-341.[Medline] [Order article via Infotrieve]
• Coetzee D., Hildebrand K., Boulle A., et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18:887-895.[CrossRef][Medline] [Order article via Infotrieve]
• Laurent C., Diakhate N., Gueye NF, et al. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS. 2002;16: 1363-1370.[CrossRef][Medline] [Order article via Infotrieve]
• Weidle PJ, Malamba S., Mwebaze R., et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet. 2002;360:34-40.[CrossRef][Medline] [Order article via Infotrieve]
• Duong M., Piroth L., Peytavin G., et al. Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response. Clin Infect Dis. 2001;33:386-392.[CrossRef][Medline] [Order article via Infotrieve]
• Fairley CK, Permana A., Read TR Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting. HIV Med. 2005;6:366-369.[CrossRef][Medline] [Order article via Infotrieve]
• Antinori A., Cozzi-Lepri A., Ammassari A., et al. Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART. Antivir Ther. 2004;9:291-296.[Medline] [Order article via Infotrieve]
• Nieuwkerk PT, Oort FJ Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38:445-448.[CrossRef][Medline] [Order article via Infotrieve]
• Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386-395.[Medline] [Order article via Infotrieve]
• Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003;37:1112-1118.[CrossRef][Medline] [Order article via Infotrieve]
• Melbourne KM, Geletko SM, Brown SL, Willey-Lessne C., Chase S., Fisher A. Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Read. 1999;9:329-338.[Medline] [Order article via Infotrieve]
• Liu H., Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.[Abstract/Free Full Text]
• Paterson DL, Potoski B., Capitano B. Measurement of adherence to antiretroviral medications. J Acquir Immune Defic Syndr. 2002;31(suppl 3):S103-S106.[Medline] [Order article via Infotrieve]
• Calmy A., Ford N., Hirschel B., et al. HIV viral load monitoring in resource-limited regions: optional or necessary? Clin Infect Dis. 2007;44:128-134.[CrossRef][Medline] [Order article via Infotrieve]
• Schooley RT Viral load testing in resource-limited settings. Clin Infect Dis. 2007;44:139-140.[CrossRef][Medline] [Order article via Infotrieve]
• Bagchi S., Kempf MC, Westfall AO, Maherya A., Willig J., Saag MS Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings? Clin Infect Dis. 2007;44:135-138.[CrossRef][Medline] [Order article via Infotrieve]
• Rosen S., Fox MP, Gill CJ Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4:e298. doi:10.371/ journal.pmed.0040298.[CrossRef][Medline] [Order article via Infotrieve]
• Ferradini L., Jeannin A., Pinoges L., et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006; 367:1335-1342.[CrossRef][Medline] [Order article via Infotrieve]
• Erikstrup C., Kallestrup P., Zinyama R., et al. Predictors of mortality in a cohort of HIV-1-infected adults in rural Africa. J Acquir Immune Defic Syndr. 2007;44:478-483.[CrossRef][Medline] [Order article via Infotrieve]
• Madec Y., Laureillard D., Pinoges L., et al. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. AIDS. 2007;21:351-359.[Medline] [Order article via Infotrieve]
• Wools-Kaloustian K., Kimaiyo S., Diero L., et al. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS. 2006;20:41-48.[Medline] [Order article via Infotrieve]
• Muyingo SK, Walker AS, Reid A., et al. Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the dart trial in Uganda and Zimbabwe. J Acquir Immune Defic Syndr. 2008;48:468-475.[CrossRef][Medline] [Order article via Infotrieve]
• Bisson GP, Rowh A., Weinstein R., Gaolathe T., Frank I., Gross R. Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana. J Acquir Immune Defic Syndr. 2008;49: 107-110.[CrossRef][Medline] [Order article via Infotrieve]
• Bisson GP, Gross R., Bellamy S., et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008;5:e109.[CrossRef][Medline] [Order article via Infotrieve]
• San Lio MM, Carbini R., Germano P., et al. Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against aids and malnutrition program in Mozambique. Clin Infect Dis. 2008;46: 1609-1616.[CrossRef][Medline] [Order article via Infotrieve]
• Paterson DL, Swindells S., Mohr J., et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.[Abstract/Free Full Text]
• Singh N., Berman SM, Swindells S., et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29:824-830.[Medline] [Order article via Infotrieve]
• Golin CE, Liu H., Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17:756-765.[CrossRef][Medline] [Order article via Infotrieve]
• Stirratt MJ, Remien RH, Smith A., Copeland OQ, Dolezal C., Krieger D. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behav. 2006;10:483-493.[CrossRef][Medline] [Order article via Infotrieve]
• Shah B., Walshe L., Saple DG, et al. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007;44:1235-1244.[CrossRef][Medline] [Order article via Infotrieve]
• Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12:255-266.[CrossRef][Medline] [Order article via Infotrieve]
• Walsh JC, Horne R., Dalton M., Burgess AP, Gazzard BG Reasons for non-adherence to antiretroviral therapy: patients' perspectives provide evidence of multiple causes. AIDS Care. 2001;13:709-720.[CrossRef][Medline] [Order article via Infotrieve]

This version was published on March 1, 2009

Journal of the International Association of Physicians in AIDS Care (JIAPAC), Vol. 8, No. 2, 139-147 (2009)
DOI: 10.1177/1545109709332470


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bajunirwe, F. Articles by Sethi, A. K. Search for Related Content PubMed PubMed Citation Articles by Bajunirwe, F. Articles by Sethi, A. K. Pubmed/NCBI databases Medline Plus Health Information AIDS Medicines Rural Health Concerns Social Bookmarking                         What's this?